Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
A significant legitimization signal came in December 2025 when the World Health Organization conditionally endorsed long-term GLP-1 therapy for obesity and added these medications to its Essential Medicines List for high-risk type 2 diabetes patients
While there is no established link between GLP-1 medications and worsening of Crohn's disease, the data to definitively confirm their safety in this population is still evolving
I guess this comes down to the growing use of social media and exposure to biohacking/optimal health gurus (i.e ben greenfield, thomas de lauer, huberman, ergogenic health etc)
doi:10.1016/j.biopha.2018.06.129 41
US$ 28.91
US$ 21.78
US$ 23.21
US$ 27.65
US$ 23.70
US$ 25.03
US$ 20.05
US$ 24.99
US$ 29.34
